Cellectar Biosciences Inc (CLRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 5,794 | 5,691 | 4,851 | 6,038 | 6,401 |
| Operating Income | -5,794 | -5,691 | -4,851 | -6,038 | -6,401 |
| Other Income | 140 | 395 | 407 | 590 | -203 |
| Pre-tax Income | -5,654 | -5,295 | -4,444 | -5,448 | -6,604 |
| Net Income Continuous | -5,654 | -5,295 | -4,444 | -5,448 | -6,604 |
| Net Income | $-5,654 | $-5,295 | $-4,444 | $-5,448 | $-6,604 |
| EPS Basic Total Ops | -1.33 | 0.75 | -1.41 | -3.39 | -4.30 |
| EPS Basic Continuous Ops | -1.33 | 0.74 | -1.41 | -3.39 | -4.30 |
| EPS Diluted Total Ops | -1.33 | 0.75 | -1.41 | -3.39 | -4.30 |
| EPS Diluted Continuous Ops | -1.33 | 0.74 | -1.41 | -3.39 | -4.30 |
| EPS Diluted Before Non-Recurring Items | -1.33 | -0.53 | -1.41 | -3.39 | -3.90 |
| EBITDA(a) | $-5,904 | $-5,641 | $-4,798 | $-5,982 | $-6,345 |